We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Will the Rs 150-crore research and development (R&D) fund for the pharmaceutical
industry finally get off the blocks, a good five years after it was first announced
in budget 2000-01? "We now have the fund and it will be the complete Rs
150 crore, not just the interest amount of about Rs 10 crore.
Britain's health minister will submit a report this week, backing drugs for
Alzheimer's disease that the UK health watchdog wants withdrawn from the state-run
health service, the Observer newspaper reported on Sunday.
Europe must do more to ensure the safety of medicines following recent product
scandals, European Commission Vice President Guenter Verheugen said on Friday.
Teva, the largest non-patent medicine producer in the world, will hold the stake
of Tianjin Hualida Biotechnology Co. Ltd (Hualida) in Tianjin, a municipality
in north China, reliable sources said.
Despite some remaining areas of concern, the level of patent protection to foreign
pharmaceuticals products has improved considerably, with the onset of the UAE's
WTO commitments this year helping to resolve matters.
LAM Pharmaceutical, a biomedical company focused on the development and commercialization
of novel wound healing and transdermal drug delivery systems, announced that
a series of official launch presentations of the LAM IPM Wound Gel in Ecuador
will take place the week of April 18, 2005.